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Editorial on the Research Topic
Supramolecular Metal-Based Entities for Biomedical and Biological Applications
The biomedical and biological application of supramolecular metal-based structures—including
the discrete supramolecular coordination complexes (SCCs) and polymeric metal organic
frameworks (MOFs)—is an emergent research area. In fact, in the last decade, a number of studies
demonstrated the potential of these supramolecular compounds as novel anticancer drugs, drug
delivery systems, and imaging agents, as well as for molecular recognition of relevant biomolecules.
The present article collection includes an overview of the examples of discrete 2D- and
3D-supramolecular metal-based systems, with focus on cancer therapy, in the review of Ahmedova.
The review covers the specific case of 2Dmetalacycles, as well as 3Dmetallacages, helicates, capsules
and barrels, and marks out some key tendencies in relation to their biological activity and potential
areas of biomedical application.
Of note, the point of view of one of the pioneers in this research area, Therrien, is provided in a
review focused on the role of the second coordination sphere, including H-bonding, hydrophobic,
electrostatic, and van der Waals interactions, in the biological activity of arene ruthenium
metalla-assemblies. These types of interactions are crucial in the design of supramolecular entities
implemented for molecular recognition.
Thus, a number of original papers in this issue report on the use of selected metallacages as
cytotoxic agents against human cancer cells. For example, Vasdev et al. reported on [Pd2L4]
4+
metallacages featuring bis-quinoline and bis-isoquinoline-based ligands. The bis-quinolone-based
cage was found to be helical while the bis-isoquinoline-based system was lantern shaped. The
binding of the anticancer drug cisplatin was also examined. It was shown that only the bis-
isoquinoline cage interacted with the drug, suggesting that the helical twist interferes with the
host-guest interaction. Both new cages were shown to be more cytotoxic against cancer cell lines
than related pyridyl based systems.
Interestingly,Wang et al. provided the proof-of-concept of using nanoprecipitation to formulate
hydrophobic Pt(II)-organic cages.
Along the same line, the antiproliferative effects of a self-assembled hexagonal Pd(II) macrocycle
against a small panel of cancer cell lines were found comparable to cisplatin in the paper by
Singh et al.
Furthermore, Sun et al. explored the potential of encapsulating Ru(II) polypyridyl complexes in
macrocyclic host compounds, namely cucurbit[10]urils (Q[10]), to reduce the toxicity of Ru(II)
complexes. The Q[10] encapsulation enhanced the pharmacokinetics of one of the ruthenium
complexes which could potentially enable the complex to be used as a new type of antimicrobial
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agent. The host-guest complex between twisted cucurbit[14]uril
and thioflavin T was also explored for sensing of non-fluorescent
triazole fungicides by Fan et al.
Peptides are highly versatile building blocks, encoding
precise structural and functional information within their
amino acid sequence, which can be used to design and
synthesize novel supramolecular metal-based helicates structures
endowed with molecular recognition properties. In the work by
Gómez-González et al. the modification of the T4 Fibritin foldon
with metal-chelating bipyridines allowed the obtainment of Fe
helicates which display good in vitroDNA binding and selectivity
toward three-way DNA junctions.
Among the features of supramolecular-based scaffolds,
their host-guest chemistry is certainly interesting to exploit
them as drug delivery systems or as biosensors. Thus, Woods
et al. reported on a series of exo-functionalized [Pd2L4]
4+
metallacages featuring 2,6-bis(pyridin-3-ylethynyl)pyridine)
ligands. The encapsulation of the anticancer drug cisplatin in
selected cages has been studied using a combination of NMR
spectroscopy methods, and the obtained results show that if the
solvent is of sufficient polarity, cisplatin encapsulation can easily
occur in the hydrophobic cavity of the cage despite the absence
of hydrogen-bond accepting cavity-facing residues.
A novel aspect of this research field concerns the use
of supramolecular organometallic complexes, whereby the
(organic) linker is forming the organometallic bond to the
metal node, for therapy. Thus, the antimicrobial and anticancer
properties of organometallic Ag(I) and Au(I) pillarplexes
were explored in different bacterial and human cancer cells,
respectively (Pöthig et al.). The obtained results showed more
relevant bioactivity in the case of the silver compounds.
Within this framework, Barnard et al. developed the synthesis
of Au(I) and Pd(II) N-heterocyclic carbene (NHC) complexes
derived from tetra-imidazolium linked macrocycles for anion
sensing. Interestingly, some of the Ag(I) and the analogous
Au(I) complexes adopted intriguing hexanuclear structures with
the general formula [M6L3]
6+. It is envisaged that these novel
scaffolds could allow the slow release of metal ions for the
treatment of bacterial infections.
Overall, as highlighted in the contributions to this special
issue, the myriad of possible metal-based supramolecular
structures and their almost limitless modularity and tunability
suggests that the biomedical applications of these complex
chemical entities will continue to emerge.
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